Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 March 2022 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Drone training
Khanyisile Khanyi, trainer at Alpha One Aviation, and Alinah Nomthandazo Bokopt from Free State News, at the drone awareness training presented on the UFS South Campus.

A mixed group of 20 young people attended a Digital Television Broadcasting training session on the South Campus of the University of the Free State (UFS). The excited group of students received their first practical on drone awareness. 

The UFS South Campus was the venue for this session, which formed part of a pilot project for drone awareness training. If the training curriculum is approved by the aviation accrediting body, the UFS Division of Social Responsibility Projects will collaborate with Sollywood South Africa to present a six-month course consisting of theory and practical sessions, including a focus on heritage and culture, converting from analogue to digital format, drone conferencing, creative writing, safety management, entrepreneurship, event management, and drone manufacturing. 

Promoting self-employment

Campus Principal, Dr Marinkie Madiope, is thrilled about the possibilities of this pilot development opportunity. “Not many people in South Africa manufacture drones,” she says.

The university will ensure that the training is fit for purpose and that the qualification is recognised. “With its focus on impact and visibility in 2022, the UFS will impact disadvantaged communities by equipping the unemployed youth with the necessary skills to create their own employment.”

The service providers will source funding from the MICTSETA (Media, Information and Communication Technologies Sector Education and Training Authority) to formalise the course content. 

Investment in scarce skills

Thandeka Mosholi, Head: Social Responsibility, Enterprise, and Community Engagement on the UFS South Campus, says this project will not only contribute to job creation, but it will also bridge the gap in areas where there is a shortage of skills, such as drone manufacturing. “The skills obtained through this project also align with the Fourth Industrial Revolution,” Mosholi adds. 

Dr Zama Qampi, Executive Producer at Sollywood South Africa, says the company will erect a warehouse in the Free State later this year, specifically for the drone project.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept